Electrospun Nanofibers: Shaping the Future of Controlled and Responsive Drug Delivery
Materials · 07.11.2023 · 16 (22) · 7062
DOI: 10.3390/ma16227062 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Materials, online erschienen am 07.11.2023. Verfasst von Michael Wildy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Jersey Health Foundation, National Science Foundation, Rowan University.
Abstract (Originalsprache)
Electrospun nanofibers for drug delivery systems (DDS) introduce a revolutionary means of administering pharmaceuticals, holding promise for both improved drug efficacy and reduced side effects. These biopolymer nanofiber membranes, distinguished by their high surface area-to-volume ratio, biocompatibility, and biodegradability, are ideally suited for pharmaceutical and biomedical applications. One of their standout attributes is the capability to offer the controlled release of the active pharmaceutical ingredient (API), allowing custom-tailored release profiles to address specific diseases and administration routes. Moreover, stimuli-responsive electrospun DDS can adapt to conditions at the drug target, enhancing the precision and selectivity of drug delivery. Such localized API delivery paves the way for superior therapeutic efficiency while diminishing the risk of side effects and systemic toxicity. Electrospun nanofibers can foster better patient compliance and enhanced clinical outcomes by amplifying the therapeutic efficiency of routinely prescribed medications. This review delves into the design principles and techniques central to achieving controlled API release using electrospun membranes. The advanced drug release mechanisms of electrospun DDS highlighted in this review illustrate their versatility and potential to improve the efficacy of medical treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ 08028, USA.
ORCID-Profile: Ping Lu
Förderung
- New Jersey Health Foundation
- National Science Foundation
- Rowan University
Zitieren
APA
Wildy, M., & Lu, P. (2023). Electrospun Nanofibers: Shaping the Future of Controlled and Responsive Drug Delivery. Materials, 16(22), 7062. https://doi.org/10.3390/ma16227062
Vancouver
Wildy M, Lu P. Electrospun Nanofibers: Shaping the Future of Controlled and Responsive Drug Delivery. Materials. 2023;16(22):7062. doi:10.3390/ma16227062
BibTeX
@article{Wildy2023,
author = {Wildy, Michael and Lu, Ping},
title = {Electrospun Nanofibers: Shaping the Future of Controlled and Responsive Drug Delivery},
journal = {Materials},
year = {2023},
volume = {16},
number = {22},
pages = {7062},
doi = {10.3390/ma16227062}
}
EUVIMED